支气管切除症中中性粒细胞功能障碍:病理生理学见解和新兴的向疗法
1RAK Medical & Health Sciences University.
Multidisciplinary respiratory medicine
|October 20, 2025
概括
支气管病的新疗法针对中性粒细胞功能障碍,这是这种慢性呼吸道疾病的关键驱动因素. 新兴疗法和生物标志物提供了个性化的方法来改善患者的治疗结果.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 支气管病是一种慢性呼吸道疾病,其特征是不可逆转的支气管扩张和持续的炎症.
- 目前的治疗方法往往不足,无法解决功能失调的中性粒细胞的核心问题.
研究的目的:
- 审查了解支气管炎症中中性粒细胞驱动机制的最新进展.
- 为突出这一复杂疾病的新兴向治疗方法.
主要方法:
- 2020-2025年关于中性粒细胞活性,生物标志物和临床试验的研究文献综述.
- 来自实验模型,随机对照试验 (WILLOW,ASPEN) 和ERS指南 (2023-2024) 的数据综合.
主要成果:
- 中性粒细胞通过血清蛋白酶和中性粒细胞细胞外陷 (NET) 形成,促进支气管切除症组织损伤.
- 新兴疗法包括DPP-1抑制剂 (brensocatib),CXCR2抗体,PI3K抑制剂和NET向剂.
- 像中性粒细胞弹性酶活性和代谢表型这样的生物标志物可以个性化治疗.
结论:
- 向中性粒细胞功能障碍是改善支气管切除症护理的有希望的策略.
- 保持免疫调节与感染控制之间的平衡至关重要.
- 将新型疗法与生物标记指导和可治疗特征方法相结合,对于更好的结果至关重要.
更多相关视频
08:33A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
12.1K
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
11.6K
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
COPD: Management Using Bronchodilators and Corticosteroids
692
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
692
Drugs Used in Lower Respiratory Disorders: Overview
995
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
995
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Cystic Fibrosis: Management
434
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
434
